Is Pirfenidone/Isrifenidone a hormonal drug? Analysis of pharmacological effects and treatment principles

Pirfenidone is an anti-fibrotic drug mainly used to treat idiopathic pulmonary fibrosis (IPF). It is not a hormonal drug, but a small molecule compound with dual anti-inflammatory and anti-fibrotic effects. Its main mechanism of action is to inhibit the fibrosis process, reduce the excessive proliferation of fibroblasts and collagen deposition, reduce scar formation in lung tissue, and slow down the decline of lung function in IPF patients.

The anti-fibrotic effect of pirfenidone is closely related to its regulation of pro-fibrotic factors such as transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF). TGF-β is an important factor in the occurrence and progression of IPF. It can stimulate fibroblast proliferation and promote collagen synthesis, while pirfenidone reduces the formation of fibrotic tissue by inhibiting the TGF-β signaling pathway.

In addition, the drug can also inhibit the release of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), thereby reducing the damage of inflammation to lung tissue. Clinical studies have shown that pirfenidone can slow down the decline of lung function, prolong the time for patients without disease progression, and improve the quality of life of IPF patients to a certain extent. However, unlike traditional hormonal drugs (such as glucocorticoids), pirfenidone does not cause typical hormonal side effects, such as weight gain, increased blood sugar, or osteoporosis. Therefore, it is considered a safer long-term anti-fibrotic treatment option and has been approved by several countries for the treatment of IPF.

However, there are still some adverse effects of pirfenidone that require concern, including photosensitivity reactions, nausea, decreased appetite, gastrointestinal discomfort, and abnormal liver function. Patients need to avoid direct sunlight while taking it and regularly monitor liver function to ensure medication safety.

Reference materials:https://www.esbriet.com/